+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Malaria Therapeutics Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • August 2026
  • Region: Global
  • Grand View Research
  • ID: 6285275
REQUEST CUSTOMIZATION
Description Jump to:
The global malaria therapeutics market size was valued at USD 3.1 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 5.0 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. The Middle East & Africa dominated the market, accounting for the largest revenue share of 47.1% in 2025. The malaria therapeutics industry growth is driven by the continued burden of malaria in endemic regions, particularly across sub-Saharan Africa and parts of the Asia Pacific, where sustained transmission creates consistent demand for effective treatment options.

The malaria therapeutics industry growth is driven by the continued burden of malaria in endemic regions, particularly across sub-Saharan Africa and parts of the Asia Pacific, where sustained transmission creates consistent demand for effective treatment options.

Growth in the market is supported by government-led malaria control programs, funding from international health organizations, and the increasing availability of artemisinin-based combination therapies (ACTs) through public health initiatives. Rising surveillance for drug-resistant Plasmodium falciparum strains has encouraged pharmaceutical companies and research organizations to advance the development of novel antimalarial therapies and combination regimens. In addition, improvements in diagnostic access and early case detection have strengthened timely treatment, contributing to better disease management. For instance, in July 2025, Novartis, in collaboration with Medicines for Malaria Venture (MMV), received Swissmedic approval for Coartem Baby (artemether-lumefantrine), the first malaria treatment specifically developed for newborns and young infants, addressing a long-standing treatment gap in malaria-endemic regions and supporting broader access to age-appropriate antimalarial therapies.

Global Malaria Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global malaria therapeutics market report based on drug class, therapeutic indication, route of administration, distribution channel, and region:

Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)

  • Artemisinin-based Combination Therapies (ACTs)
  • Non-Artemisinin Antimalarial Drugs
  • 8-Aminoquinolines

Therapeutic Indication Outlook (Revenue, USD Billion, 2021 - 2033)

  • Uncomplicated Malaria
  • Severe Malaria
  • Relapse Prevention (Radical Cure)
  • Malaria Chemoprophylaxis

Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)

  • Oral
  • Parenteral

Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Government & Institutional Procurement

Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Therapeutic Indication
1.2.3. Route of Administration
1.2.4. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. The internal database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Malaria Therapeutics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Malaria Therapeutics Market: Drug Class Business Analysis
4.1. Drug Class Market Share, 2025 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, Drug Class, 2021 to 2033 (USD Billion)
4.4. Artemisinin-based Combination Therapies (ACTs)
4.4.1. Artemisinin-based Combination Therapies (ACTs) Market, 2021 - 2033 (USD Billion)
4.5. Non-Artemisinin Antimalarial Drugs
4.5.1. Non-Artemisinin Antimalarial Drugs Market, 2021 - 2033 (USD Billion)
4.6. 8-Aminoquinolines
4.6.1. 8-Aminoquinolines Market, 2021 - 2033 (USD Billion)
Chapter 5. Malaria Therapeutics Market: Therapeutic Indication Business Analysis
5.1. Therapeutic Indication Market Share, 2025 & 2033
5.2. Therapeutic Indication Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, Therapeutic Indication, 2021 to 2033 (USD Billion)
5.4. Uncomplicated Malaria
5.4.1. Uncomplicated Malaria Market, 2021 - 2033 (USD Billion)
5.5. Severe Malaria
5.5.1. Severe Malaria Market, 2021 - 2033 (USD Billion)
5.6. Relapse Prevention (Radical Cure)
5.6.1. Relapse Prevention (Radical Cure) Market, 2021 - 2033 (USD Billion)
5.7. Malaria Chemoprophylaxis
5.7.1. Malaria Chemoprophylaxis Market, 2021 - 2033 (USD Billion)
Chapter 6. Malaria Therapeutics Market: Route of Administration Business Analysis
6.1. Route of Administration Market Share, 2025 & 2033
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, Route of Administration, 2021 to 2033 (USD Billion)
6.4. Oral
6.4.1. Oral Market, 2021 - 2033 (USD Billion)
6.5. Parenteral
6.5.1. Parenteral Market, 2021 - 2033 (USD Billion)
Chapter 7. Malaria Therapeutics Market: Distribution Channel Business Analysis
7.1. Distribution Channel Market Share, 2025 & 2033
7.2. Distribution Channel Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, Distribution Channel, 2021 to 2033 (USD Billion)
7.4. Hospital Pharmacies
7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
7.5. Retail Pharmacies
7.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
7.6. Online Pharmacies
7.6.1. Online Pharmacies Market, 2021 - 2033 (USD Billion)
7.7. Government & Institutional Procurement
7.7.1. Government & Institutional Procurement Market, 2021 - 2033 (USD Billion)
Chapter 8. Malaria Therapeutics Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. North America Malaria Therapeutics Market Estimates and Forecasts, Country, 2021 - 2033 (USD Billion)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Framework
8.4.2.5. U.S. Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Framework
8.4.3.5. Canada Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Framework
8.4.4.5. Mexico Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5. Europe
8.5.1. Europe Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Framework
8.5.2.5. UK Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Framework
8.5.3.5. Germany Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement Framework
8.5.4.5. France Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Regulatory Framework
8.5.5.4. Reimbursement Framework
8.5.5.5. Italy Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Target Disease Prevalence
8.5.6.3. Regulatory Framework
8.5.6.4. Reimbursement Framework
8.5.6.5. Spain Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Target Disease Prevalence
8.5.7.3. Regulatory Framework
8.5.7.4. Reimbursement Framework
8.5.7.5. Denmark Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Target Disease Prevalence
8.5.8.3. Regulatory Framework
8.5.8.4. Reimbursement Framework
8.5.8.5. Sweden Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Target Disease Prevalence
8.5.9.3. Regulatory Framework
8.5.9.4. Reimbursement Framework
8.5.9.5. Norway Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6. Asia Pacific
8.6.1. Asia Pacific Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Framework
8.6.2.5. Japan Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Framework
8.6.3.5. China Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Framework
8.6.4.5. India Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Framework
8.6.5.5. Australia Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Regulatory Framework
8.6.6.4. Reimbursement Framework
8.6.6.5. South Korea Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Target Disease Prevalence
8.6.7.3. Regulatory Framework
8.6.7.4. Reimbursement Framework
8.6.7.5. Thailand Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7. Latin America
8.7.1. Latin America Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Target Disease Prevalence
8.7.2.3. Regulatory Framework
8.7.2.4. Reimbursement Framework
8.7.2.5. Brazil Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Target Disease Prevalence
8.7.3.3. Regulatory Framework
8.7.3.4. Reimbursement Framework
8.7.3.5. Argentina Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.8. Middle East and Africa
8.8.1. Middle East and Africa Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Target Disease Prevalence
8.8.2.3. Regulatory Framework
8.8.2.4. Reimbursement Framework
8.8.2.5. South Africa Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Target Disease Prevalence
8.8.3.3. Regulatory Framework
8.8.3.4. Reimbursement Framework
8.8.3.5. Saudi Arabia Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Target Disease Prevalence
8.8.4.3. Regulatory Framework
8.8.4.4. Reimbursement Framework
8.8.4.5. UAE Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Target Disease Prevalence
8.8.5.3. Regulatory Framework
8.8.5.4. Reimbursement Framework
8.8.5.5. Kuwait Malaria Therapeutics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Novartis AG
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. GSK plc
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Sanofi
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. Cipla Limited
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. Ipca Laboratories Limited
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Sun Pharmaceutical Industries Limited
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Ajanta Pharma Limited
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Strides Pharma Science Limited
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Shin Poong Pharmaceutical Co., Ltd.
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. KPC Pharmaceuticals, Inc.
9.5.10.1. Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Malaria Therapeutics Market, region, 2021 - 2033 (USD Billion)
Table 4 Global Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 5 Global Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 6 Global Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 7 Global Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 8 North America Malaria Therapeutics Market, country, 2021 - 2033 (USD Billion)
Table 9 North America Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 10 North America Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 11 North America Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 12 North America Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 13 U.S. Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 14 U.S. Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 15 U.S. Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 16 U.S. Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 17 Canada Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 18 Canada Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 19 Canada Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 20 Canada Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 21 Mexico Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 22 Mexico Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 23 Mexico Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 24 Mexico Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 25 Europe Malaria Therapeutics Market, country, 2021 - 2033 (USD Billion)
Table 26 Europe Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 27 Europe Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 28 Europe Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 29 Europe Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 30 UK Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 31 UK Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 32 UK Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 33 UK Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 34 Germany Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 35 Germany Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 36 Germany Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 37 Germany Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 38 France Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 39 France Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 40 France Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 41 France Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 42 Italy Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 43 Italy Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 44 Italy Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 45 Italy Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 46 Spain Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 47 Spain Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 48 Spain Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 49 Spain Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 50 Norway Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 51 Norway Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 52 Norway Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 53 Norway Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 54 Denmark Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 55 Denmark Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 56 Denmark Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 57 Denmark Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 58 Sweden Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 59 Sweden Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 60 Sweden Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 61 Sweden Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 62 Asia Pacific Malaria Therapeutics Market, country, 2021 - 2033 (USD Billion)
Table 63 Asia Pacific Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 64 Asia Pacific Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 65 Asia Pacific Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 66 Asia Pacific Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 67 Japan Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 68 Japan Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 69 Japan Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 70 Japan Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 71 China Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 72 China Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 73 China Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 74 China Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 75 India Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 76 India Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 77 India Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 78 India Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 79 Australia Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 80 Australia Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 81 Australia Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 82 Australia Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 83 South Korea Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 84 South Korea Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 85 South Korea Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 86 South Korea Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 87 Thailand Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 88 Thailand Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 89 Thailand Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 90 Thailand Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 91 Latin America Malaria Therapeutics Market, country, 2021 - 2033 (USD Billion)
Table 92 Latin America Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 93 Latin America Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 94 Latin America Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 95 Latin America Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 96 Brazil Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 97 Brazil Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 98 Brazil Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 99 Brazil Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 100 Argentina Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 101 Argentina Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 102 Argentina Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 103 Argentina Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 104 Middle East & Africa Malaria Therapeutics Market, country, 2021 - 2033 (USD Billion)
Table 105 Middle East & Africa Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 106 Middle East & Africa Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 107 Middle East & Africa Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 108 Middle East & Africa Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 109 South Africa Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 110 South Africa Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 111 South Africa Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 112 South Africa Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 113 Saudi Arabia Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 114 Saudi Arabia Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 115 Saudi Arabia Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 116 Saudi Arabia Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 117 UAE Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 118 UAE Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 119 UAE Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 120 UAE Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
Table 121 Kuwait Malaria Therapeutics Market, drug class, 2021 - 2033 (USD Billion)
Table 122 Kuwait Malaria Therapeutics Market, therapeutic Indication, 2021 - 2033 (USD Billion)
Table 123 Kuwait Malaria Therapeutics Market, route of administration, 2021 - 2033 (USD Billion)
Table 124 Kuwait Malaria Therapeutics Market, distribution channel, 2021 - 2033 (USD Billion)
List of Figures
Fig. 1 Malaria therapeutics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Competitive landscape
Figure 10 Malaria therapeutics market dynamics
Figure 11 Malaria therapeutics market: Porter’s five forces analysis
Figure 12 Malaria therapeutics market: PESTLE analysis
Figure 13 Drug Class market, 2021 - 2033 (USD Billion)
Figure 14 Artemisinin-based combination therapies (ACTs) market, 2021 - 2033 (USD Billion)
Figure 15 Non-artemisinin antimalarial drugs market, 2021 - 2033 (USD Billion)
Figure 16 8-Aminoquinolines market, 2021 - 2033 (USD Billion)
Figure 17 Therapeutic Indication market, 2021 - 2033 (USD Billion)
Figure 18 Uncomplicated malaria market, 2021 - 2033 (USD Billion)
Figure 19 Severe malaria market, 2021 - 2033 (USD Billion)
Figure 20 Relapse prevention (radical cure) market, 2021 - 2033 (USD Billion)
Figure 21 Malaria chemoprophylaxis market, 2021 - 2033 (USD Billion)
Figure 22 Route of Administration market, 2021 - 2033 (USD Billion)
Figure 23 Oral market, 2021 - 2033 (USD Billion)
Figure 24 Parenteral market, 2021 - 2033 (USD Billion)
Figure 25 Distribution channel market, 2021 - 2033 (USD Billion)
Figure 26 Hospital pharmacies market, 2021 - 2033 (USD Billion)
Figure 27 Retail pharmacies market, 2021 - 2033 (USD Billion)
Figure 28 Online pharmacies market, 2021 - 2033 (USD Billion)
Figure 29 Government & institutional procurement market, 2021 - 2033 (USD Billion)
Figure 30 Malaria therapeutics market revenue, region
Figure 31 Regional marketplace: Key takeaways
Figure 32 North America malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 33 U.S. country dynamics
Figure 34 U.S. malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 35 Canada country dynamics
Figure 36 Canada malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 37 Mexico country dynamics
Figure 38 Mexico malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 39 Europe malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 40 UK country dynamics
Figure 41 UK malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 42 Germany country dynamics
Figure 43 Germany malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 44 France country dynamics
Figure 45 France malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 46 Italy country dynamics
Figure 47 Italy malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 48 Spain country dynamics
Figure 49 Spain malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 50 Norway country dynamics
Figure 51 Norway malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 52 Sweden country dynamics
Figure 53 Sweden malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 54 Denmark country dynamics
Figure 55 Denmark malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 56 Asia Pacific malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 57 Japan country dynamics
Figure 58 Japan malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 59 China country dynamics
Figure 60 China malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 61 India country dynamics
Figure 62 India malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 63 Australia country dynamics
Figure 64 Australia malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 65 South Korea country dynamics
Figure 66 South Korea malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 67 Thailand country dynamics
Figure 68 Thailand malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 69 Latin America malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 70 Brazil country dynamics
Figure 71 Brazil malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 72 Argentina country dynamics
Figure 73 Argentina malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 74 MEA malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 75 South Africa country dynamics
Figure 76 South Africa malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 77 Saudi Arabia country dynamics
Figure 78 Saudi Arabia malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 79 UAE country dynamics
Figure 80 UAE malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 81 Kuwait country dynamics
Figure 82 Kuwait malaria therapeutics market, 2021 - 2033 (USD Billion)
Figure 83 Company categorization
Figure 84 Company market position analysis
Figure 85 Strategic framework

Companies Mentioned

  • Novartis AG
  • GSK plc
  • Sanofi
  • Cipla Limited
  • Ipca Laboratories Limited
  • Sun Pharmaceutical Industries Limited
  • Ajanta Pharma Limited
  • Strides Pharma Science Limited
  • Shin Poong Pharmaceutical Co., Ltd.
  • KPC Pharmaceuticals, Inc.

Related Reports

Antimalarial Drugs Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Antimalarial Drugs Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 198 Pages
  • Global
From
Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report by Disease (Dengue, Rabies, Trachoma, Chagas Disease), by Product (Drugs, Vaccines), by Region, and Segment Forecasts, 2025-2033 - Product Image

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report by Disease (Dengue, Rabies, Trachoma, Chagas Disease), by Product (Drugs, Vaccines), by Region, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Quinine Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Quinine Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 189 Pages
  • Global
From
Quinine Sulfate Market 2024 - Product Image

Quinine Sulfate Market 2024

  • Report
  • 175 Pages
  • Global
From
Africa Pharmaceutical Market Size, Share & Trends Analysis Report by Molecule Type (Biologics & Biosimilars), by Product, by Type, by Disease, by Formulation, by Age Group, by Route of Administration, by End-user, by Country, and Segment Forecasts, 2025-2033 - Product Image

Africa Pharmaceutical Market Size, Share & Trends Analysis Report by Molecule Type (Biologics & Biosimilars), by Product, by Type, by Disease, by Formulation, by Age Group, by Route of Administration, by End-user, by Country, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Africa
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.